COSMO BIO, 59% Increase in Ordinary Profit for The Current Fiscal Year

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Fri Feb 14, 2025 3:30 pm JST Earnings

3386 COSMO BIO COMPANY, LIMITED 【J-GAAP】

Earnings Report

COSMO BIO COMPANY, LIMITED <3386> [TSE Std] announced its financial results after the market closed on February 14th (15:30). The consolidated ordinary profit for the fiscal year ending December 2024 dropped 44.3% from the previous period to 364 million yen. In the fiscal year ending December 2025, the profit is expected to recover in a V-shape, increasing by 59.3% to 580 million yen.

In the most recent three-month period, from October to December (4Q), the consolidated ordinary profit/loss turned to a loss of 20 million yen (compared to a profit of 99 million yen in the same period last year). The operating profit/loss margin drastically worsened from 2.9% in the same period last year to -1.9%.

Kabutan News

Actual Results

Historical Performance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Dec, 2022	9,553	816	790	517	89.1	36	Feb 14, 2023	J-GAAP
Dec, 2023	9,340	519	653	442	76.0	30	Feb 14, 2024	J-GAAP
Dec, 2024	10,037	318	364	262	45.1	50	Feb 14, 2025	J-GAAP
YoY	+7.5%	-38.7%	-44.3%	-40.7%	-40.7%

Full Year Results vs. Previous Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Dec, 2024 Guidance	9,800	390	450	310	53.9	50	Aug 5, 2024	J-GAAP
Dec, 2024 Results	10,037	318	364	262	45.1	50	Feb 14, 2025	J-GAAP
Revision Rate	+2.4%	-18.5%	-19.1%	-15.5%	-16.4%

Current Period Guidance

H1 Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jan - Jun, 2024	5,129	322	337	258	44.2	14	Aug 5, 2024	J-GAAP
Jan - Jun, 2025 Guidance	5,500	290	360	280	49.1	25	Feb 14, 2025	J-GAAP
YoY	+7.2%	-9.9%	+6.8%	+8.5%	+11.0%

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Dec, 2023	9,340	519	653	442	76.0	30	Feb 14, 2024	J-GAAP
Dec, 2024	10,037	318	364	262	45.1	50	Feb 14, 2025	J-GAAP
Dec, 2025 Guidance	10,700	490	580	430	75.4	50	Feb 14, 2025	J-GAAP
YoY	+6.6%	+54.1%	+59.3%	+64.1%	+67.3%

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Oct - Dec, 2023	2,463	72	99	76	13.1	2.9	Feb 14, 2024	J-GAAP
Jan - Mar, 2024	2,943	305	299	230	39.6	10.4	May 9, 2024	J-GAAP
Apr - Jun, 2024	2,186	17	38	28	4.8	0.8	Aug 5, 2024	J-GAAP
Jul - Sep, 2024	2,280	47	47	33	5.7	2.1	Nov 7, 2024	J-GAAP
Oct - Dec, 2024	2,628	-51	-20	-29	-5.0	-1.9	Feb 14, 2025	J-GAAP
YoY	+6.7%	－	－	－	－